ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Pharsight Corp (MM)

Pharsight Corp (MM) (PHST)

5.48
0.00
(0.00%)
Closed January 17 4:00PM
5.48
0.00
( 0.00% )
Pre Market: 7:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
5.48
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
5.48
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

PHST Latest News

Pharsight Launches PK Accelerator(TM)

PK Accelerator Bundled Solution Accelerates Pharmacokinetic Analysis and Reporting MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading...

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Talk Will Cover the Use of Pharsight Software for In-Vitro / In-Vivo Correlation Modeling in Drug Development MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Pharsight(R) Corporation...

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Dr. Farkad Ezzet Will Present on the Strategic Value of Literature Modeling to Assess Disease Progression and Drug Attributes in Clinical Development MOUNTAIN VIEW, Calif., June 17...

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Dr. Laurent Claret Will Present Case Studies on the Value of Drug-Disease Modeling to Predict Efficacy and Survival Benefits of Anticancer Agents MOUNTAIN VIEW, Calif., June 12...

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Dr. Robert Leary Will Discuss Computational Methods for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified Programming Approaches of Population Model User Interfaces MOUNTAIN VIEW...

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Dr. Helen Kastrissios Will Present on Communicating the Value of Pharmacodynamic Modeling in Clinical Drug Development MOUNTAIN VIEW, Calif., May 27 /PRNewswire-FirstCall/ -- Pharsight...

Pharsight Hosts European PKS User Meeting

Second Annual European Meeting to be Held In Paris MOUNTAIN VIEW, Calif., May 23 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic...

Pharsight Achieves $7.6 Million In Quarterly Revenue

Fourth Quarter Revenue Highest in Company History; Full Year Revenue Up 13% MOUNTAIN VIEW, Calif., May 8 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of...

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Dr. Bill Poland Will Present on the Strategic Use of Incorporating Adherence Data into Clinical Trial Predictions of Antiviral Therapies MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/...

Pharsight Strengthens Senior Management Team

John Murphy Appointed as New Senior Vice President of Consulting Services MOUNTAIN VIEW, Calif., April 29 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PHST - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is $ 5.48
What is the 1 year trading range for share price?
has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASSTAsset Entities Inc
$ 0.9098
(95.87%)
31.08M
HSDTHelius Medical Technologies Inc
$ 1.29
(71.77%)
14.53M
BBGIBeasley Broadcast Group Inc
$ 13.17
(59.25%)
19
EDRYEuroDry Ltd
$ 18.08
(58.88%)
12
LXEOLexeo Therapeutics Inc
$ 7.99
(57.59%)
1
GOEVCanoo Inc
$ 0.40
(-70.37%)
1.79M
ELVNEnliven Therapeutics Inc
$ 10.11
(-52.91%)
20
CUBLionheart Holdings
$ 5.11
(-49.51%)
1
ALRSAlerus Financial Corporation
$ 12.01
(-38.79%)
13
MDXGMiMedx Group Inc
$ 6.01
(-34.10%)
9
CRKNCrown Electrokinetics Corporation
$ 0.1455
(16.40%)
80.61M
ASSTAsset Entities Inc
$ 0.9098
(95.87%)
31.08M
NIVFNewGenIvf Group Ltd
$ 0.3429
(-1.75%)
20.94M
HSDTHelius Medical Technologies Inc
$ 1.29
(71.77%)
14.53M
CGBSCrown LNG Holdings Ltd
$ 0.8507
(13.76%)
12.64M

PHST Discussion

View Posts
No Posts Found

Your Recent History

Delayed Upgrade Clock